SPIA
VERA icon

Steward Partners Investment Advisory’s Vera Therapeutics VERA Stock Holding History

Steward Partners Investment Advisory’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15K Buy
372
+20
+6% +$862 ﹤0.01% 3371
2025
Q4 		$17.8K Buy
352
+2
+0.6% +$71 ﹤0.01% 3184
2025
Q3 		$10.2K Buy
+350
New +$8.09K ﹤0.01% 3399
2025
Q2 		– Sell
-350
Closed -$8.41K – 4249
2025
Q1 		$8.41K Hold
350
– – ﹤0.01% 3169
2024
Q4 		$14.8K Buy
+350
New +$15.5K ﹤0.01% 2928

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Steward Partners Investment Advisory's VERA Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Vera Therapeutics (VERA) stake by 5.7% in Q1 2026, buying an estimated $862 and bringing the position to 372 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #3371.

Steward Partners Investment Advisory first reported a position in VERA in Q4 2024 and has held it in 5 quarters since. The position peaked at $17.8K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Steward Partners Investment Advisory held 372 shares of Vera Therapeutics worth $15K as of Q1 2026.
  • Steward Partners Investment Advisory bought 20 Vera Therapeutics shares in Q1 2026, an estimated $862.
  • Vera Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3371 holding.
  • Steward Partners Investment Advisory first reported a position in Vera Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Steward Partners Investment Advisory's Vera Therapeutics position peaked at $17.8K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.